Annual Report Analysis of Listed Vitamin Companies in China/data publication
Vitamin industry hot topics in 2014:
To clearly describe China's vitamin industry, CCM has collected lots of information in various ways. In this report, development situation of vitamin listed companies has been described in detail, including company profile, financial performance, product mix, market share, and investment opportunity.
What to report:In this report, the 9 listed vitamin companies have been analyzed exhaustively from the following aspects:
In the next few years, the vitamin industry in China will continue to be promising. On the whole, it’s worth investing in it.
- On 19 March, 2014, BASF released a statement that its citral production line in Germany plant suffered a fire and had to close down. BASF's total citral capacity accounts for more than 60% of the global capacity, thus the fire leads to the tight supply of citral and has a huge impact on the downstream of vitamin A, fragrance and flavor, vitamin E and other products. Though BASF's citral resumed production in April, domestic supply situation didn't change.
- On 11 July, 2014, DSM announced that it had reached an agreement to acquire Aland Nutraceutical Holding, Ltd., a leading producer of vitamin C in China. Through the acquisitions, DSM can further strengthen its status in vitamin C market and expand its domains all over the world of human nutrition and health care, animal nutrition and health care and personal care.
- On 29 September, 2014, Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd. announced that Hefei Yifan Bio-Pharm Co., Ltd., a subsidiary of Xinfu Pharmaceutical, will merge with Hefei Yifan Pharmaceutical Co., Ltd., another subsidiary of Xinfu Pharmaceutical. After the completion of the merger, Yifan Bio-Pharm will continue to exist while Yifan Pharmaceutical will be dismissed and deregistered.
- On 5 Nov., 2014, Guangzhou Lonza (Nansha) Co., Ltd. launched a 15,000 t/a vitamin B3 (niacinamide) and formally put into operation, which further enlarged the production capacity of China's vitamin B3. It's estimated that there is a risk of excess capacity.
To clearly describe China's vitamin industry, CCM has collected lots of information in various ways. In this report, development situation of vitamin listed companies has been described in detail, including company profile, financial performance, product mix, market share, and investment opportunity.
What to report:In this report, the 9 listed vitamin companies have been analyzed exhaustively from the following aspects:
- Revenue and net profit of the listed vitamin companies, 2009-2013;
- Main product structure of the listed vitamin companies by main business revenue, 2013;
- Revenue and gross profit margin of vitamin business of the listed vitamin companies, 2009-2013;
- Regional distribution of the listed vitamin companies by main business revenue, 2012 and 2013;
- Top 5 customers of the listed vitamin companies by total revenue, 2012 and 2013.
- R&D investment of the listed vitamin companies, 2012 and 2013
In the next few years, the vitamin industry in China will continue to be promising. On the whole, it’s worth investing in it.
1 OVERVIEW
2 RANKING OF THE 9 LISTED VITAMIN COMPANIES IN CHINA
2.1 Geographic distribution of listed vitamin companies in China
2.2 Revenue
2.3 Profit
2.4 Total assets
2.5 R&D investment
3 ANALYSIS OF LISTED VITAMIN COMPANIES
3.1 North China Pharmaceutical Co., Ltd.
3.2 Zhejiang Medicine Co., Ltd.
3.3 Zhejiang NHU Company Ltd.
3.4 Northeast Pharmaceutical Group Co., Ltd.
3.5 PKU HealthCare Corp., Ltd.
3.6 Brother Enterprises Holding Co., Ltd.
3.7 Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd.
3.8 Xiamen Kingdomway Group Company
3.9 Hubei Guangji Pharmaceutical Co., Ltd.
4 CONCLUSIONS
2 RANKING OF THE 9 LISTED VITAMIN COMPANIES IN CHINA
2.1 Geographic distribution of listed vitamin companies in China
2.2 Revenue
2.3 Profit
2.4 Total assets
2.5 R&D investment
3 ANALYSIS OF LISTED VITAMIN COMPANIES
3.1 North China Pharmaceutical Co., Ltd.
3.2 Zhejiang Medicine Co., Ltd.
3.3 Zhejiang NHU Company Ltd.
3.4 Northeast Pharmaceutical Group Co., Ltd.
3.5 PKU HealthCare Corp., Ltd.
3.6 Brother Enterprises Holding Co., Ltd.
3.7 Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd.
3.8 Xiamen Kingdomway Group Company
3.9 Hubei Guangji Pharmaceutical Co., Ltd.
4 CONCLUSIONS
LIST OF TABLES
Table 2.1 -1 Basic information of listed vitamin companies in China
Table 2.2-1 Revenue of the 9 listed vitamin companies in China, 2012 and 2013
Table 2.3-1 Net profit of 9 listed vitamin companies in China, 2013
Table 2.4-1 Total assets of 9 listed vitamin companies in China, 2012 and 2013
Table 2.5-1 R&D investment of nine listed vitamin enterprises in China, 2012 and 2013
Table 3.1 -1 Regional distribution of North China Pharmaceutical by main business revenue,2012 and 2013
Table 3.1 -2 Top 5 customers of North China Pharmaceutical by revenue, 2012 and 2013
Table 3.1 -3 R&D investment of North China Pharmaceutical, 2012 and 2013
Table 3.2-1 Regional distribution of Zhejiang Medicine by main business revenue,2012 and 2013
Table 3.2-2 Top 5 customers of Zhejiang Medicine by revenue, 2013
Table 3.2-3 R&D investment of Zhejiang Medicine, 2011-2013
Table 3.3-1 Regional distribution of NHU by main business revenue, 2012 and 2013
Table 3.3-2 Top 5 customers of NHU by revenue, 2012 and 2013
Table 3.3-3 R&D investment of NHU, 2011-2013
Table 3.4-1 Regional distribution of Northeast Pharmaceutical by main business revenue,2012 and 2013
Table 3.4-2 Top 5 customers of Northeast Pharmaceutical by revenue, 2012 and 2013
Table 3.4-3 R&D investment of Northeast Pharmaceutical, 2012 and 2013
Table 3.5-1 Regional distribution of PKU HealthCare by main business revenue,2012 and 2013
Table 3.5-2 Top 5 customers of PKU HealthCare by revenue, 2012 and 2013
Table 3.5-3 R&D investment of PKU HealthCare, 2012 and 2013
Table 3.6-1 Regional distribution of Brother Enterprises by main business revenue,2012 and 2013
Table 3.6-2 Top 5 customers of Brother Enterprises by revenue,2012 and 2013
Table 3.6-3 R&D investment of Brother Enterprises,2012 and 2013
Table 3.7-1 Regional distribution of Xinfu Pharmaceutical by main business revenue,2012 and 2013
Table 3.7-2 Top 5 customers of Xinfu Pharmaceutical by revenue,2012 and 2013
Table 3.7-3 R&D investment of Xinfu Pharmaceutical,2012 and 2013
Table 3.8-1 Regional distribution of Xiamen Kingdomway by main business revenue,2012 and 2013
Table 3.8-2 Top 5 customers of Xiamen Kingdomway by revenue, 2012 and 2013
Table 3.8-3 R&D investment of Xiamen Kingdomway, 2011 -2013
Table 3.9-1 Regional distribution of Guangji Pharmaceutical by main business revenue,2012 and 2013
Table 3.9-2 Top 5 customers of Guangji Pharmaceutical by revenue,2012 and 2013
Table 3.9-3 R&D investment of Guangji Pharmaceutical,2012 and 2013
Table 2.1 -1 Basic information of listed vitamin companies in China
Table 2.2-1 Revenue of the 9 listed vitamin companies in China, 2012 and 2013
Table 2.3-1 Net profit of 9 listed vitamin companies in China, 2013
Table 2.4-1 Total assets of 9 listed vitamin companies in China, 2012 and 2013
Table 2.5-1 R&D investment of nine listed vitamin enterprises in China, 2012 and 2013
Table 3.1 -1 Regional distribution of North China Pharmaceutical by main business revenue,2012 and 2013
Table 3.1 -2 Top 5 customers of North China Pharmaceutical by revenue, 2012 and 2013
Table 3.1 -3 R&D investment of North China Pharmaceutical, 2012 and 2013
Table 3.2-1 Regional distribution of Zhejiang Medicine by main business revenue,2012 and 2013
Table 3.2-2 Top 5 customers of Zhejiang Medicine by revenue, 2013
Table 3.2-3 R&D investment of Zhejiang Medicine, 2011-2013
Table 3.3-1 Regional distribution of NHU by main business revenue, 2012 and 2013
Table 3.3-2 Top 5 customers of NHU by revenue, 2012 and 2013
Table 3.3-3 R&D investment of NHU, 2011-2013
Table 3.4-1 Regional distribution of Northeast Pharmaceutical by main business revenue,2012 and 2013
Table 3.4-2 Top 5 customers of Northeast Pharmaceutical by revenue, 2012 and 2013
Table 3.4-3 R&D investment of Northeast Pharmaceutical, 2012 and 2013
Table 3.5-1 Regional distribution of PKU HealthCare by main business revenue,2012 and 2013
Table 3.5-2 Top 5 customers of PKU HealthCare by revenue, 2012 and 2013
Table 3.5-3 R&D investment of PKU HealthCare, 2012 and 2013
Table 3.6-1 Regional distribution of Brother Enterprises by main business revenue,2012 and 2013
Table 3.6-2 Top 5 customers of Brother Enterprises by revenue,2012 and 2013
Table 3.6-3 R&D investment of Brother Enterprises,2012 and 2013
Table 3.7-1 Regional distribution of Xinfu Pharmaceutical by main business revenue,2012 and 2013
Table 3.7-2 Top 5 customers of Xinfu Pharmaceutical by revenue,2012 and 2013
Table 3.7-3 R&D investment of Xinfu Pharmaceutical,2012 and 2013
Table 3.8-1 Regional distribution of Xiamen Kingdomway by main business revenue,2012 and 2013
Table 3.8-2 Top 5 customers of Xiamen Kingdomway by revenue, 2012 and 2013
Table 3.8-3 R&D investment of Xiamen Kingdomway, 2011 -2013
Table 3.9-1 Regional distribution of Guangji Pharmaceutical by main business revenue,2012 and 2013
Table 3.9-2 Top 5 customers of Guangji Pharmaceutical by revenue,2012 and 2013
Table 3.9-3 R&D investment of Guangji Pharmaceutical,2012 and 2013
LIST OF FIGURES
Figure 2.1 -1 Geographic distribution of listed vitamin companies in China,2013
Figure 3.1 -1 Revenue and net profit of North China Pharmaceutical,2009-2013
Figure 3.1 -2 Revenue and gross profit margin of vitamin business of North China Pharmaceutical,2009-2013
Figure 3.1 -3 Product structure of North China Pharmaceutical by main business revenue,2013
Figure 3.2-1 Revenue and net profit of Zhejiang Medicine, 2009-2013
Figure 3.2-2 Revenue and gross profit margin of nutrition business of Zhejiang Medicine,2009-2013
Figure 3.2-3 Product structure of Zhejiang Medicine by main business revenue,2013
Figure 3.3-1 Total revenue and net profit of NHU,2009-2013
Figure 3.3-2 Revenue and gross profit margin of nutrition business of NHU,2009-2013
Figure 3.3-3 Product structure of NHU by main business revenue, 2013
Figure 3.4-1 Total revenue and net profit of Northeast Pharmaceutical, 2009-2013
Figure 3.4-2 Revenue and gross profit margin of API business of Northeast Pharmaceutical,2009-2013
Figure 3.4-3 Product structure of Northeast Pharmaceutical by main business revenue,2013
Figure 3.5-1 Revenue and net profit of PKU HealthCare,2009-2013
Figure 3.5-2 Revenue and gross profit margin of API business of PKU HealthCare,2009-2013
Figure 3.5-3 Product structure of PKU HealthCare by main business revenue,2013
Figure 3.6-1 Total revenue and net profit of Brother Enterprises, 2011 -2013
Figure 3.6-2 Revenue and gross profit margin of vitamin business of Brother Enterprises,2011-2013
Figure 3.6-3 Product structure of Brother Enterprises by main business revenue,2013
Figure 3.7-1 Total revenue and net profit of Xinfu Pharmaceutical, 2009-2013
Figure 3.7-2 Revenue and gross profit margin of vitamin business of Xinfu Pharmaceutical,2009-2013
Figure 3.7-3 Product structure of Xinfu Pharmaceutical by main business revenue, 2013
Figure 3.8-1 Total revenue and net profit of Xiamen Kingdomway, 2011-2013
Figure 3.8-2 Revenue and gross profit margin of vitamin business of Xiamen Kingdomway,2011-2013
Figure 3.8-3 Product structure of Xiamen Kingdomway by main business revenue,2013
Figure 3.9-1 Total revenue and net profit of Guangji Pharmaceutical,2009-2013
Figure 3.9-2 Revenue and gross profit margin of API business of Guangji Pharmaceutical,2009-2013
Figure 3.9-3 Product structure of Guangji Pharmaceutical by main business revenue,2013
COMPANIES MENTIONED
North China Pharmaceutical Co., Ltd.
Zhejiang Medicine Co., Ltd.
Zhejiang NHU Company Ltd.
Northeast Pharmaceutical Group Co., Ltd.
PKU HealthCare Corp., Ltd.
Brother Enterprises Holding Co., Ltd.
Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd.
Xiamen Kingdomway Group Company
Hubei Guangji Pharmaceutical Co., Ltd.
Figure 2.1 -1 Geographic distribution of listed vitamin companies in China,2013
Figure 3.1 -1 Revenue and net profit of North China Pharmaceutical,2009-2013
Figure 3.1 -2 Revenue and gross profit margin of vitamin business of North China Pharmaceutical,2009-2013
Figure 3.1 -3 Product structure of North China Pharmaceutical by main business revenue,2013
Figure 3.2-1 Revenue and net profit of Zhejiang Medicine, 2009-2013
Figure 3.2-2 Revenue and gross profit margin of nutrition business of Zhejiang Medicine,2009-2013
Figure 3.2-3 Product structure of Zhejiang Medicine by main business revenue,2013
Figure 3.3-1 Total revenue and net profit of NHU,2009-2013
Figure 3.3-2 Revenue and gross profit margin of nutrition business of NHU,2009-2013
Figure 3.3-3 Product structure of NHU by main business revenue, 2013
Figure 3.4-1 Total revenue and net profit of Northeast Pharmaceutical, 2009-2013
Figure 3.4-2 Revenue and gross profit margin of API business of Northeast Pharmaceutical,2009-2013
Figure 3.4-3 Product structure of Northeast Pharmaceutical by main business revenue,2013
Figure 3.5-1 Revenue and net profit of PKU HealthCare,2009-2013
Figure 3.5-2 Revenue and gross profit margin of API business of PKU HealthCare,2009-2013
Figure 3.5-3 Product structure of PKU HealthCare by main business revenue,2013
Figure 3.6-1 Total revenue and net profit of Brother Enterprises, 2011 -2013
Figure 3.6-2 Revenue and gross profit margin of vitamin business of Brother Enterprises,2011-2013
Figure 3.6-3 Product structure of Brother Enterprises by main business revenue,2013
Figure 3.7-1 Total revenue and net profit of Xinfu Pharmaceutical, 2009-2013
Figure 3.7-2 Revenue and gross profit margin of vitamin business of Xinfu Pharmaceutical,2009-2013
Figure 3.7-3 Product structure of Xinfu Pharmaceutical by main business revenue, 2013
Figure 3.8-1 Total revenue and net profit of Xiamen Kingdomway, 2011-2013
Figure 3.8-2 Revenue and gross profit margin of vitamin business of Xiamen Kingdomway,2011-2013
Figure 3.8-3 Product structure of Xiamen Kingdomway by main business revenue,2013
Figure 3.9-1 Total revenue and net profit of Guangji Pharmaceutical,2009-2013
Figure 3.9-2 Revenue and gross profit margin of API business of Guangji Pharmaceutical,2009-2013
Figure 3.9-3 Product structure of Guangji Pharmaceutical by main business revenue,2013
COMPANIES MENTIONED
North China Pharmaceutical Co., Ltd.
Zhejiang Medicine Co., Ltd.
Zhejiang NHU Company Ltd.
Northeast Pharmaceutical Group Co., Ltd.
PKU HealthCare Corp., Ltd.
Brother Enterprises Holding Co., Ltd.
Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd.
Xiamen Kingdomway Group Company
Hubei Guangji Pharmaceutical Co., Ltd.
